Lymphoma Group

The NCRI Lymphoma Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of lymphoma. The group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for lymphoma patients.  

The NCRI Lymphoma Group consists of an executive group, chaired by Professor Andrew Davies, which provides oversight of the research landscape and proactively identifies opportunities for the group. The NCRI Lymphoma Group also has several study groups that develop research in areas of strategic need. 

How can I get involved?

Join the NCRI Lymphoma Network

Group members

Professor Andrew Davies

Chair

Andrew Davies is Professor of Haematological Oncology in the Cancer Sciences Unit in the Faculty ...

Professor Andrew Davies

Chair

Andrew Davies is Professor of Haematological Oncology in the Cancer Sciences Unit in the Faculty of Medicine, University Hospital Southampton. He completed his training in Medical Oncology at St Bartholomew’s Hospital in London, and as a Cancer Research UK clinical fellow he undertook a PhD examining the molecular mechanisms underlying transformation of follicular lymphoma to more aggressive histological sub-types.

Prof. Davies specialises in the treatment of malignant lymphoma and the use of high-dose chemotherapy. He has a particular interest in the investigation of monoclonal antibody-containing therapies applied to lymphoma and also in the translation of biomarkers and novel therapies to the clinical arena.  He has extensive experience in early phase trials, including leading several first in man lymphoma studies.

He is the past Chair of the UK National Cancer Research Institute High Grade Lymphoma Study Group and Director of Cancer Research UK/National Institute of Health Southampton Experimental Cancer Medicine Centre. He is also the Wessex regional lead for cancers in Teenagers and Young Adults.

Dr Graham Collins

Deputy Chair

Dr Collins trained in medicine at Cambridge and London before undergoing haematology training at ...

Dr Graham Collins

Deputy Chair

Dr Collins trained in medicine at Cambridge and London before undergoing haematology training at Oxford, completing a DPhil in the molecular biology of the Reed-Sternberg cell. He is now lymphoma lead clinician for the Thames Valley cancer network and consultant at the Churchill hospital in Oxford. His research interests are in Hodgkin and aggressive non-Hodgkin lymphoma and has lead both the Hodgkin and T-cell lymphoma national study groups. He leads a number of investigator-initiated trials, has contributed to several national clinical guidelines and works on a number of projects with the National Institute of Health and Care Excellence (NICE). He is clinical expert on the national CAR-T panel for lymphoma and co-course director for the national Lymphoma management course.

More from NCRI